Profund Advisors’s Array Biopharma Inc ARRY Stock Holding History

Profund Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,430	Closed	-$205K	–	1347
2019 Q2	$205K	Buy	+4,430	New	+$124K	0.01%	1131
2014 Q3	–	Sell	-11,655	Closed	-$53K	–	1504
2014 Q2	$53K	Sell	11,655 -345	-3%	-$1.43K	﹤0.01%	1529
2014 Q1	$56K	Buy	+12,000	New	+$60.3K	﹤0.01%	1555

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Profund Advisors's ARRY Position: Q3 2019 in Review

Profund Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 4,430 shares — an estimated $205K sold.

Profund Advisors first reported a position in ARRY in Q1 2014 and held it in 3 quarters. The position peaked at $205K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Profund Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Profund Advisors sold 4,430 Array Biopharma Inc shares in Q3 2019, an estimated $205K.
Profund Advisors first reported a position in Array Biopharma Inc in Q1 2014 and held it in 3 quarters.
Profund Advisors's Array Biopharma Inc position peaked at $205K in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Profund Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.